Sudbury, MA, United States of America

Paul Allan Renhowe

This inventor holds 1 USPTO granted patent and 3 published patent applications and 7 EPO patents. Top assignee: Tisento Therapeutics Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Allan Renhowe. Retrieved from https://idiyas.com/inventor/paul-allan-renhowe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Paul Allan Renhowe: Innovator at Cyclerion Therapeutics

Introduction

Paul Allan Renhowe is an accomplished inventor based in Sudbury, Massachusetts. He is currently associated with Cyclerion Therapeutics, Inc., a company focused on developing innovative therapies for serious diseases. Although he has not registered any patents to date, his contributions to the field of therapeutics are noteworthy.

Latest Patents

As of now, Paul Allan Renhowe holds no patents. However, his work at Cyclerion Therapeutics may lead to future innovations that could significantly impact the industry.

Career Highlights

Throughout his career, Paul has been involved in various projects that aim to advance medical science. His role at Cyclerion Therapeutics allows him to collaborate with leading experts in the field, contributing to the development of groundbreaking therapies.

Collaborations

Paul has worked alongside talented colleagues such as Glen Robert Rennie and Rajesh R Iyengar. Their combined expertise fosters a collaborative environment that encourages innovation and progress in therapeutic development.

Conclusion

Paul Allan Renhowe is a dedicated inventor whose work at Cyclerion Therapeutics holds promise for future advancements in medicine. His collaborative efforts with esteemed colleagues further enhance the potential for impactful innovations in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…